LUSPATERCEPT (ACE-536) INCREASES HEMOGLOBIN AND DECREASES TRANSFUSION BURDEN AND LIVER IRON CONCENTRATION IN ADULTS WITH BETA-THALASSEMIA: PRELIMINARY RESULTS FROM A PHASE 2 STUDY

被引:0
|
作者
Piga, A. [1 ]
Perrotta, S. [2 ]
Borgna-Pignatti, C. [3 ]
Gamberini, M. R. [3 ]
Melpignano, A. [4 ]
Voskaridou, E. [5 ]
Caruso, V. [6 ]
Filosa, A. [7 ]
Aydinok, Y. [8 ]
Zhang, X. [9 ]
Wilson, D. [9 ]
Laadem, A. [10 ]
Sherman, M. [9 ]
Attie, K. [9 ]
机构
[1] Univ Turin, Turin, Italy
[2] Univ Naples 2, Naples, Italy
[3] Univ Ferrara, I-44100 Ferrara, Italy
[4] Osped A Perrino, Brindisi, Italy
[5] Laikon Gen Hosp, Athens, Greece
[6] Garibaldi Hosp, Catania, Italy
[7] AORN A Cardarelli, Naples, Italy
[8] Ege Univ, Pediat Hematol, Izmir, Turkey
[9] Acceleron Pharma, Cambridge, MA USA
[10] Celgene Corp, Summit, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
S136
引用
收藏
页码:17 / 17
页数:1
相关论文
共 29 条
  • [1] ACE-536 Increases Hemoglobin and Decreases Transfusion Burden and Serum Ferritin in Adults with Beta-Thalassemia: Preliminary Results from a Phase 2 Study
    Piga, Antonio G.
    Perrotta, Silverio
    Melpignano, Angela
    Borgna-Pignatti, Caterina
    Voskaridou, Ersi
    Caruso, Vincenzo
    Filosa, Aldo
    Aydinok, Yesim
    Condon, Carrie
    Wilson, Dawn M.
    Laadem, Adberrahmane
    Sherman, Matthew L.
    Attie, Kenneth M.
    BLOOD, 2014, 124 (21)
  • [2] ACE-536 INCREASES HEMOGLOBIN LEVELS IN ADULTS WITH BETA-THALASSEMIA: PRELIMINARY RESULTS FROM A PHASE 2 STUDY
    Piga, A.
    Melpignano, A.
    Perrotta, S.
    Borgna-Pignatti, C.
    Caruso, V.
    Voskaridou, E.
    Filosa, A.
    Aydinok, Y.
    Condon, C.
    Wilson, D.
    Sherman, M.
    Attie, K.
    HAEMATOLOGICA, 2014, 99 : 230 - 231
  • [3] Luspatercept Increases Hemoglobin, Decreases Transfusion Burden and Improves Iron Overload in Adults with Beta-Thalassemia
    Piga, Antonio G.
    Tartaglione, Immacolata
    Gamberini, Rita
    Voskaridou, Ersi
    Melpignano, Angela
    Ricchi, Paolo
    Caruso, Vincenzo
    Pietrangelo, Antonello
    Zhang, Xiaosha
    Wilson, Dawn M.
    Leneus, Ashley
    Laadem, Abderrahmane
    Sherman, Matthew L.
    Attie, Kenneth M.
    BLOOD, 2016, 128 (22)
  • [4] Luspatercept (ACE-536) Reduces Disease Burden, Including Anemia, Iron Overload, and Leg Ulcers, in Adults with Beta-Thalassemia: Results from a Phase 2 Study
    Piga, Antonio
    Perrotta, Silverio
    Gamberini, M. Rita
    Voskaridou, Ersi
    Melpignano, Angela
    Filosa, Aldo
    Pietrangelo, Antonello
    Caruso, Vincenzo
    Forni, Gian Luca
    Zhang, Xiaosha
    Bellevue, Ashley
    Wilson, Dawn
    Laadem, Abderrahmane
    Sherman, Matthew L.
    Attie, Kenneth M.
    BLOOD, 2015, 126 (23)
  • [5] LUSPATERCEPT DECREASES TRANSFUSION BURDEN AND LIVER IRON CONCENTRATION IN REGULARLY TRANSFUSED ADULTS WITH BETA-THALASSEMIA
    Piga, A.
    Perrotta, S.
    Melpignano, A.
    Borgna-Pignatti, C.
    Gamberini, M. R.
    Voskaridou, E.
    Caruso, V.
    Ricchi, P.
    Pietrangelo, A.
    Zhang, X.
    Wilson, D.
    Bellevue, A.
    Laadem, A.
    Sherman, M.
    Attie, K.
    HAEMATOLOGICA, 2016, 101 : 338 - 339
  • [6] LUSPATERCEPT INCREASES HEMOGLOBIN AND DECREASES TRANSFUSION BURDEN IN ADULTS WITH B-THALASSEMIA
    Piga, A.
    Tartaglione, I.
    Gamberini, R.
    Voskaridou, E.
    Melpignano, A.
    Ricchi, P.
    Caruso, V.
    Pietrangelo, A.
    Zhang, X.
    Wilson, D.
    Leneus, A.
    Laadem, A.
    Sherman, M. L.
    Attie, K. M.
    Linde, P. G.
    HAEMATOLOGICA, 2017, 102 : 15 - 16
  • [7] LUSPATERCEPT INCREASES HEMOGLOBIN, REDUCES LIVER IRON CONCENTRATION, AND IMPROVES QUALITY OF LIFE IN NON-TRANSFUSION DEPENDENT ADULTS WITH BETA-THALASSEMIA
    Piga, A.
    Perrotta, S.
    Melpignano, A.
    Borgna-Pignatti, C.
    Gamberini, M. R.
    Voskaridou, E.
    Caruso, V.
    Ricchi, P.
    Pietrangelo, A.
    Zhang, X.
    Wilson, D.
    Bellevue, A.
    Laadem, A.
    Sherman, M.
    Attie, K.
    HAEMATOLOGICA, 2016, 101 : 304 - 304
  • [8] ACE-536 Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from a Phase 2 Study
    Platzbecker, Uwe
    Germing, Ulrich
    Giagounidis, Aristoteles
    Goetze, Katharina
    Kiewe, Philipp
    Mayer, Karin
    Ottman, Oliver
    Radsak, Markus P.
    Wolff, Thomas
    Haase, Detlef
    Hankin, Monty
    Wilson, Dawn M.
    Laadem, Adberrahmane
    Sherman, Matthew L.
    Attie, Kenneth M.
    BLOOD, 2014, 124 (21)
  • [9] LUSPATERCEPT DECREASES TRANSFUSION BURDEN AND LIVER IRON CONCENTRATION IN REGULARLY TRANSFUSED ADULTS WITH β-THALASSAEMIA
    Piga, Antonio G.
    Perrotta, Silverio
    Melpignano, Angela
    Borgna-Pignatti, Caterina
    Gamberini, M. Rita
    Voskaridou, Ersi
    Caruso, Vincenzo
    Ricchi, Paolo
    Pietrangelo, Antonello
    Zhang, Xiaosha
    Wilson, Dawn M.
    Bellevue, Ashley
    Laadem, Abderrahmane
    Sherman, Matthew L.
    Attie, Kenneth M.
    HAEMATOLOGICA, 2017, 102 : 89 - 90
  • [10] ACE-536 INCREASES HEMOGLOBIN LEVELS IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY
    Platzbecker, U.
    Germing, U.
    Giagounidis, A.
    Goetze, K.
    Kiewe, P.
    Mayer, K.
    Ottmann, O.
    Radsak, M.
    Wolff, T.
    Hankin, M.
    Wilson, D.
    Sherman, M.
    Attie, K.
    HAEMATOLOGICA, 2014, 99 : 500 - 500